¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14
±³À°ÀÏÀÚ : 2024-06-14
±³À°Àå¼Ò : ¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ, 2F ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Áø´ÜÀ¯ÀüÇÐȸ

´ã´çÀÚ : Á¤¹Ì¼±
¿¬¶ôó : 02-772-9004

À̸ÞÀÏ : ksgd.office@gmail.com

±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 160,000¿ø  

ºñ°í »çÀüµî·Ïºñ : Á¤È¸¿ø 8¸¸¿ø(Àü¹®ÀÇ/±³¼ö/±âŸ), Á¤È¸¿ø 6¸¸¿ø(ÀÓ»óº´¸®»ç), Âü°¡È¸¿ø 12¸¸¿ø(Àü¹®ÀÇ/±³¼ö), Àü°øÀÇ ¸éÁ¦, 7¸¸¿ø(ÀÓ»óº´¸®»ç/Çлý), 15¸¸¿ø(»ê¾÷°è), ÇöÀåµî·Ïºñ: Á¤È¸¿ø 9¸¸¿ø(Àü¹®ÀÇ/±³¼ö/±âŸ) Á¤È¸¿ø 7¸¸¿ø(ÀÓ»óº´¸®»ç), Âü°¡È¸¿ø 13¸¸¿ø(Àü¹®ÀÇ/±³¼ö), 8¸¸¿ø(ÀÓ»óº´¸®»ç/Çлý), 16¸¸¿ø(»ê¾÷°è)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 09:00~09:30 À¯ÀüÀÚ°Ë»ç °ü·Ã ¹ý·É ¹× Á¦µµ ¹× À¯ÀüÀÚ°Ë»çÀÇ ¸ñÀû¿¡ µû¸¥ À¯ÀüÀÚ°Ë»ç Ç׸ñ ºÐ·ù ÀÌÇØ ¹Ú°æ¼±(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 09:30~10:00 ÅÂ¾Æ ¹× ¹è¾Æ ´ë»ó À¯ÀüÀÚ °Ë»çÀÇ ¹ýÀû, À±¸®Àû À̽´ ±è¸¸Áø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 10:00~10:30 À¯ÀüÀÚ °Ë»ç ½Ç¹« – °Ë»ç´ë»ó¹°/À¯ÀüÁ¤º¸/°³ÀÎÁ¤º¸ °ü¸® ¼ÕÁö¿¬(ÀÌ¿øÀÇ·áÀç´Ü)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 12:30~13:00 HPV°Ë»ç ÀÓ»ó±Ç°í¾È ¼ö¸³ °èȹ ¹× ÇöȲ À̽ÅÈ­(¼­¿ï¾Æ»êº´¿ø »êºÎÀΰú)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 13:00~13:30 Highly Sensitive Detection of Early Stage HCC using PCR based Liquid Biopsy ±è¿µÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 13:30~14:00 Clinical Application of Urine as a Source of Liquid Biopsy for Urological Cancer ¿øµ¿ÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 14:00~14:30 Fusion Detection using Circulating Tumor DNA Assays : The Value and Challenges ±è¿µ°ï(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 15:00~15:30 Sanger RNA Sequencing without NMD Inhibition and Variant Reclassification ÇÏâÈñ(°Ç±¹ÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 15:30~16:00 RNA Sequencing Analysis Pipeline for Clinical Application ¹ÚÁ¾È£(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇA(¿¤¸®¿¡³ªÈ£ÅÚ 3F ÀÓÆ丮¾óȦ) 16:00~16:30 Introducing Single-Cell RNA Sequencing and Its Applicability Àå¹Ì¾Ö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 10:45~11:10 Longitudinal Detection of ctDNA in Non-Hodgkin Lymphoma ¼ºÁö¿¬(Çѱ¹·Î½´Áø´Ü)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 10:45~11:10 Single-Cell and Single-Microbe High-Throughput Sequencing Solution Yanquan Luo(MobiDrop)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 11:10~11:35 Evaluation of a New Sequencing Instrument, AVITI À̽ÂÅÂ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 11:10~11:35 Genetic Diagnosis Utilizing xGen Exome and mtDNA Research Solution ¼³Ã¢¾È(GCÁö³ð)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 11:35~12:00 Using Genomic Tools for Genetic Disease Investigation and Cytogenetic Screening Thomas Kleem(´Ù¿ì¹ÙÀÌ¿À¸ÞµðÄ«&ÀÏ·ç¹Ì³ª)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 11:35~12:00 Application of Biomarker Testing for Precision Medicine Approach ÀÌ°æ¾Æ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 13:00~13:30 NGS MRD for Hematologic Malignancies ±èÁøÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 13:30~14:00 Digital Droplet PCR in Hematologic Malignancies ±èÇöÁö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 14:00~14:30 Liquid Biopsy for Lymphoma ±èÈ«°æ(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 15:00~15:30 Ç÷¾×¾Ï À¯ÀüÀڰ˻翡¼­ ¹ß°ßµÇ´Â somatic variant Çؼ® ¹× º¸°í Áöħ/±Ç°í¾È ±èÇö¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 14ÀÏ ¼¼¼ÇB(¿¤¸®¿¡³ªÈ£ÅÚ 2F ÄÁº¥¼ÇȦ) 15:30~16:00 Ç÷¾×¾Ï ȯÀÚ¿¡¼­ MRD monitoring °Ë»ç °á°ú Çؼ® ¹× º¸°í Áöħ/±Ç°í¾È ±è¹Ì¿µ(¿ï»êÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14
´ÙÀ½±Û 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21182 °æ±â Á¦6ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ¾Ï ½ÉÆ÷Áö¾ö(¿ÀÇÁ¶óÀÎ/¿Â¶óÀÎ) : 2024-07-26 0 20 2024-07-02
21181 ´ë±¸ Çѱ¹¿©ÀÚÀÇ»çȸ ´ë±¸°æºÏÁöȸ 7¿ù Çмú½ÉÆ÷Áö¾ö(ºÒ¸éÁõ, ¼ö¸éÁ¦, Ȳ¹Ýº¯¼º ¹× ³ëÈ­ °ü·Ã ¾ÈÁúȯ) : 2024-07-23 0 25 2024-07-02
21180 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø (¿Â¶óÀÎ) Á¦12ȸ ¼­¿ï ÀÓ»ó¾îÁö·³Áõ ¼¼¹Ì³ª : 2024-07-21 0 32 2024-07-02
21179 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ÇнÀÀå¾Ö ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-07-21 0 40 2024-07-02
21178 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú½ºÆ÷Ã÷ÀÇÇÐȸ - Á¦2Â÷ ½ºÆ÷Ã÷ ¼Õ»ó ½ÉÆ÷Áö¾ö : 2024-07-21 0 23 2024-07-02
21177 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (2ÀÏÂ÷) : 2024-07-20 0 18 2024-07-02
21176 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦2ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-07-20 0 19 2024-07-02
21175 ¼­¿ï 21st Head and Neck Workshop (»ï¼º¼­¿ïº´¿ø & ´ëÇѵΰæºÎ¿Ü°úÇÐȸ) : 2024-07-20 0 22 2024-07-02
21174 ¼­¿ï 2024 ´ëÇÑÈ£Èí°ü¸®ÇÐȸ Á¦32Â÷ Çмú´ëȸ : 2024-07-20 0 20 2024-07-02
21173 ¼­¿ï 2024³â ´ëÇÑ°íÇ÷¾ÐÇÐȸ ´ë»çÁõÈıº¿¬±¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-07-20 0 22 2024-07-02
21172 ¼­¿ï Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20 0 19 2024-07-02
21171 ¼¼Á¾ 2024³â ´ëÇÑ°í°üÀýÇÐȸ °üÀýº¸Á¸ ½ÉÆ÷Áö¿ò : 2024-07-20 0 27 2024-07-02
21170 ¿ï»ê 2024³â Á¦7ȸ ´ëÇÑÇ׳ëÈ­ºñ´¢ÅëÇÕ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-20 0 26 2024-07-02
21169 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (1ÀÏÂ÷) : 2024-07-19 0 26 2024-07-02
21168 ¼­¿ï ´ëÇÑ»çȸÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-19 0 36 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷